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The activation of p38 MAPK in myogenic precursor cells (MPCs) is a key signal for their exit
of cell cycle and entry of the myogenic differentiation program. Therefore, identification of
the signaling mechanism that activates p38 MAPK during this process is important for the
understanding of the regulatory mechanism of muscle regeneration. This article reviews
recent findings regarding the role of inflammatory cytokine tumor necrosis factor-α (TNFα)
as a key activator of p38 MAPK during myogenesis in an autocrine/paracrine fashion, and
the signaling mechanisms that converge upon TNFα converting enzyme (TACE) to release
TNFα from differentiating MPCs in response to diverse regenerative stimuli.
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Skeletal muscle regeneration is vital for the maintenance of
muscle homeostasis, the repair of injury and the adaptation to
training. Skeletal muscle regeneration requires the re-initiation of
the myogenic program that involves the sequential expression or
repression of such transcription factors as Six1/4, Pax3/7, Myf5,
MyoD, myogenin, and MRF4 to turn on muscle-specific gene
expression in myogenic precursor cells (MPCs), known as satel-
lite cells (Bentzinger et al., 2012). The execution of the myogenic
program requires epigenetic regulations that control the activity
of the aforementioned transcription factors precisely to establish
and maintain the myogenic identity in quiescent MPCs and to
enable the proper response to environmental cues in activated
MPCs (Giordani and Puri, 2013).
A key player in epigenetic regulation of the myogenic pro-
gram is p38 MAPK. Activation of p38 MAPK is essential for the
initiation of myogenic differentiation in myoblasts and embryo
(Cuenda and Cohen, 1999; Zetser et al., 1999; Puri et al., 2000;
Wu et al., 2000; Cabane et al., 2003; Penn et al., 2004; de Angelis
et al., 2005). Activated p38 MAPK mediates the transition of pro-
liferating satellite cells into terminal differentiation and ensuing
muscle-specific gene expression through multiple actions includ-
ing the initiation of cell cycle exit by down-regulating Pax7,
the activation of key myogenic transcription factors MyoD and
MEF2, and the activation of chromatin remodeling to allow access
of MyoD and MEF2 to the myogenic loci (Lluis et al., 2006;
Giordani and Puri, 2013). In addition, the myogenesis-promoting
role of p38 MAPK has been linked to its α subtype specifically
(Cabane et al., 2003; Perdiguero et al., 2007; Palacios et al., 2010).
Thus, p38 MAPK is considered a molecular switch for the acti-
vation of myogenic differentiation, and the signaling mechanism
that mediates myogenic activation of p38 MAPK is of fundamen-
tal importance for myogenic gene expression. However, for a long
period of time the signaling mechanism that mediates p38 MAPK
activation in satellite cells during muscle regeneration was poorly
understood. This review summarizes the recent literature that
depicts a key role of TACE-mediated release of TNFα fromMPCs
in the activation of p38 MAPK during muscle regeneration.
INFLAMMATION IS CRITICAL TO MUSCLE REGENERATION
Myogenic activation of p38 MAPK is controlled either by the
developmental program, as in embryonic myogenesis, or by envi-
ronmental input, as in adult myogenesis associated with muscle
regeneration. Muscle regeneration takes place in a highly inflam-
matory environment. Inflammation has been recognized as a
key response to muscle injury required for muscle regeneration
(Tidball, 1995, 2005). Infiltrated inflammatory cells, particularly
macrophages, facilitate muscle regeneration via phagocytosis of
cellular debris and release of soluble factors that promote satellite
cell proliferation and differentiation (Cantini et al., 1994; Cantini
and Carraro, 1995; Chazaud et al., 2003). Among those soluble
factors, there are not only chemoattractants and growth factors
that are traditionally recognized as factors promoting muscle
regeneration but also cytokines that are known mainly as inflam-
matory mediators including TGFβ, leukemia inhibitory factor
(LIF) and IL-6 (Hawke and Garry, 2001; Charge and Rudnicki,
2004).
All the growth factors involved in muscle regeneration includ-
ing fibroblast growth factor (FGF), insulin-like growth factor
(IGF-I), hepatocyte growth factor (HGF), epidermal growth fac-
tor (EGF), and platelet-derived growth factor (PDGF) promote
the proliferation of satellite cells. Most of them also inhibit the
differentiation of satellite cells. Only IGF-I has been convinc-
ingly shown to promote both the proliferation and differentiation
of satellite cells (Hawke and Garry, 2001; Charge and Rudnicki,
2004). However, IGF-I is not able to activate p38 MAPK or to
inducemyogenesis when p38MAPK is inhibited (Wu et al., 2000).
Some of the cytokines including TGFα, LIF (Austin et al., 1992),
and IL-6 (Cantini et al., 1995; Munoz-Canoves et al., 2013) also
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promote satellite cell proliferation. On the other hand, TGFβ
inhibits differentiation (Massague et al., 1986; Olson et al., 1986).
However, the inflammatory cytokine TNFα has emerged as a key
mediator of myogenic differentiation due to its activation of p38
MAPK.
TNFα RECEPTOR-MEDIATED SIGNALING IS REQUIRED FOR
MYOGENESIS
Several lines of evidence support a central role of TNFα in the
activation of adult myogenesis. First, muscle regeneration takes
place in an environment with elevated TNFα levels. Mammalian
muscle constitutively synthesizes TNFα (Saghizadeh et al., 1996).
Coinciding with the onset of muscle regeneration, TNFα level
in injured muscle rises dramatically because of a strong increase
in TNFα synthesis by injured myofibers as well as TNFα release
by infiltrating inflammatory cells (Tews and Goebel, 1996; De
Bleecker et al., 1999; Zador et al., 2001; Warren et al., 2002).
Importantly, myofiber synthesis of TNFα is positively correlated
to regenerating activity (Kuru et al., 2003). At the same time,
there is an increase in TNFα receptor expression in injuredmuscle
fibers (De Bleecker et al., 1999; Zador et al., 2001), suggest-
ing a physiological role for TNFα receptor-mediated signaling
in injured muscle. Further, TNFα is constitutively expressed in
C2C12 myoblasts and a rapid increase of TNFα expression takes
place during the early hours of differentiation, which is critical to
muscle-specific gene expression, suggesting that TNFα regulates
myogenesis in an autocrine/paracrine fashion (Li and Schwartz,
2001). These data indicate an orchestrated effort by myocytes and
inflammatory cells to increase TNFα receptor-mediated signaling
in MPCs during muscle regeneration.
Second, TNFα receptor-mediated signaling is critical to myo-
genesis in diverse muscle regeneration models. TNFα receptor
double-knockout (p55−/−p75−/−) impairs strength recovery of
mouse muscle injured by freezing, which suggests the participa-
tion of TNFα in the regulation of muscle regeneration (Warren
et al., 2002). In addition, it was observed in cardiotoxin-injured
mouse muscle that TNFα receptor double-knockout increases the
expression of Cyclin D1 and decreases the expression of p21 as
well as the activation of MEF2C, resulting in a blockade of myo-
genin expression and impairment of muscle regeneration (Chen
et al., 2005). These data suggest that TNFα receptor-mediated
signaling is required for proliferating satellite cells to exit cell
cycle and enter terminal differentiation. Subsequent in vitro stud-
ies confirmed this role of TNFα. In cultured myoblasts with
TNFα receptor double-knockout the activation or expression of
early myogenic markers MEF2C, p21 and myogenin are blocked,
resulting in decreased expression of myosin heavy chain (MHC),
when differentiation is induced by either serum withdraw (Chen
et al., 2007) or mechanical stretch (Zhan et al., 2007). Further,
addition of a TNFα-neutralizing antibody to the culture medium
of myoblasts recapitulates a critical role of myoblast-released
autocrine TNFα in the activation of myogenic differentiation.
Conversely, addition of exogenous TNFα to myoblast cultures,
which mimics the elevated levels of TNFα found in injured
muscle, further increases myoblast differentiation (Chen et al.,
2007). These observations support the concept that combined
TNFα release from myocytes and inflammatory cells in injured
muscle promotes myogenesis. A more recent study by Palacios
and colleagues further demonstrated that neutralizing TNFα in
mdx mice blocks myogenesis by interfering with differentiation-
associated repression of Pax7 levels which is essential for cell cycle
exit and the progression of activated satellite cells in myogenic lin-
eage (Palacios et al., 2010). Therefore, TNFα receptor-mediated
signaling has a central role in the regulation of the exit of cell cycle
and the initiation of myogenic differentiation in satellite cells.
Third, TNFα receptor-mediated signaling promotes myogenic
differentiation through its activation of p38 MAPK. TNFα is
one of the many activators of p38 MAPK (Zarubin and Han,
2005). In myocytes TNFα receptor-associated factor 6 (TRAF6)
mediates p38 MAPK activation through Transforming growth
factor β activated kinase-1 (TAK1) (Xiao et al., 2012). However,
whether TNFα receptor-mediated signaling is critical to myo-
genic activation of p38 MAPK was unknown until such a role
has been demonstrated in diverse models of muscle regeneration.
In cardiotoxin-injured mouse muscle TNFα receptor double-
knockout blocks the activation of p38 MAPK (Chen et al., 2005).
Neutralizing TNF in mdx mice blocks p38 MAPK activation in
regenerating mdx muscle (Palacios et al., 2010). Consistent to the
in vivo findings, in cultured myoblasts TNFα receptor double-
knockout or treatment with a TNFα-neutralizing antibody blocks
p38 MAPK activation, resulting in a blockade of myogenic dif-
ferentiation similar to the effect of the pharmacological inhibitor
of p38 MAPK, SB203580 (Chen et al., 2007; Zhan et al., 2007).
Further, the activation of p38 MAPK has been shown to be essen-
tial to TNFα receptor-mediated signaling to promote myogenic
differentiation. Forced activation of p38 MAPK by the expres-
sion of a constitutively active MKK6 (MKK6bE) in the muscle of
TNFα receptor double-knockout mice rescues impaired myogen-
esis and muscle regeneration (Chen et al., 2007). These observa-
tions indicate that TNFα receptor-mediated signaling promotes
myogenesis through the activation of p38 MAPK.
TACE-MEDIATED AUTOCRINE TNFα RELEASE FROM
MYOBLASTS ACTIVATES p38 MAPK AND MYOGENESIS
TNFα is synthesized as a 26 kDa transmembrane pro-protein
and released as a 17 kDa free peptide into extracellular space
upon cleavage primarily by TNFα converting enzyme (TACE).
TACE, also known as A disintegrin and metalloprotease (ADAM)
17, is a ubiquitous transmembrane protein that belongs to the
ADAM family of disintegrin metalloproteinases (Blobel, 1997;
Black, 2002). The cleavage of TNFα from the plasma mem-
brane by TACE allows the release of free TNFα in muscle from
infiltrating inflammatory cells, primarily macrophages, as well
as myocytes as a paracrine or autocrine regulator. TACE activ-
ity is regulated posttranscriptionally by cellular signaling events
(Zhang et al., 2000, 2001; Fan et al., 2003), hence, TACE could
be a rate-limiting regulator of TNFα-mediate signaling in myo-
genesis. Importantly, in cardiotoxin-injured muscle, there is not
only an increase in TNFα synthesis but also an increase in TNFα
cleavage, which starts within 1 day and reaches the peak level
around day 3 of injury, coinciding with the activation of satellite
cells and the initiation of myogenic differentiation (Chen et al.,
2007). TNFα was also shown released by cultured proliferating
myoblasts at a low level, which is significantly increased upon
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differentiation and lasts for at least 2 days, when myogenic gene
expression is being initiated (Chen et al., 2007). Neutralizing the
TNFα released into the culture medium blocks p38 MAPK acti-
vation during myoblast differentiation induced by either serum-
withdraw (Chen et al., 2007) or mechanical stretch (Zhan et al.,
2007). Further, a dramatic increase in TACE activity is observed
in differentiating myoblasts, which is rate limiting for the acti-
vation of p38 MAPK and subsequent myogenic differentiation
(Zhan et al., 2007). Therefore, TACE-mediated autocrine TNFα
release from myoblasts activates p38 MAPK and myogenesis.
TACE ACTIVITY IN MYOBLASTS IS REGULATED BY DISTINCT
SIGNALING MECHANISMS SPECIFIC TO THE NATURE OF
MYOGENIC STIMULUS
Given that TACE-mediated autocrine TNFα release is a key step
for the activation of p38 MAPK in differentiating myoblasts,
there must be intrinsic mechanisms that control the release of
TNFα through regulating TACE activity in response to myogenic
stimuli. TACE activity is normally repressed by its physiologi-
cal inhibitor, tissue inhibitor of metalloproteinase 3 (TIMP3), a
member of the tissue inhibitor of metalloproteinase family that
plays an important role in the regulation of inflammation (Black,
2004). TIMP3 is the only one of four TIMPs that binds to the
extracellular matrix (Mohammed et al., 2003) and inhibits TACE
activity through chelating the extracellular active-site zinc with
its N-terminus (Gomis-Rüth et al., 1997; Amour et al., 1998;
Lee et al., 2005). Notably, TIMP3 is constitutively expressed in
muscle cells (Leco et al., 1994), which suggests a physiological
role for TIMP3 in muscle cells. In searching for the mechanisms
that regulate TACE activity during myogenesis, Liu et al. (2010)
recently discovered that in mouse muscle undergoing regener-
ation induced by cardiotoxin injury or functional overloading,
TIMP3 expression at mRNA and protein levels is dramatically
down-regulated within 1 day, and then recovered to normal level
when regeneration is complete. The down-regulation of TIMP3
takes place in activated satellite cells. Similar down-regulation of
TIMP3 is observed in cultured myoblasts that are differentiating
in low-serummedium. Ectopic expression of TIMP3 inmyoblasts
or muscle that counters TIMP3 down-regulation blocks p38
MAPK activation and myogenic differentiation. Further, TIMP3
down-regulation in differentiating myoblasts is mediated by
microRNA-206, a myogenesis-promoting microRNA that is
induced during myoblast differentiation (Kim et al., 2006; Rao
et al., 2006). Thus, constitutively expressed TIMP3 acts as
a gatekeeper of myogenic differentiation that helps to pre-
vent premature differentiation and maintain the satellite cell
pool. The down-regulation of TIMP3 opens the gate of dif-
ferentiation by allowing TACE to release TNFα that activates
p38 MAPK.
However, the down-regulation of TIMP3, which requires
many hours to take place, does not explain the rapid activa-
tion of p38 MAPK by TNFα observed in mechanically stretched
myoblasts (Zhan et al., 2007). More recently, Niu and colleagues
described a signaling mechanism of rapid activation of TACE
in muscle in response to mechanical loading involving the non-
receptor tyrosine kinase Src. Src plays an important role in
the transduction of mechanical stimulation into biochemical
signaling in a variety of load-sensitive cells (Han et al., 2004;
Wang et al., 2005). In cells that are mechanically stimulated,
Src undergoes phosphorylation and dephosphorylation rapidly,
which activates Src. Activated Src in turn activates its down-
stream effectors through tyrosine phosphorylation (Sai et al.,
1999). Niu et al. (2013) discovered that Src is rapidly activated
in mechanically stretched myoblasts. Src then quickly phosphory-
lates TACE that possesses the structural features of Src substrates
in its intracellular tail including a potential SH3-binding motif
(P731APQTPGR738) adjacent to a putative tyrosine phosphory-
lation motif (K696KLDKQYESL705). Utilizing an antibody raised
against this motif with phosphorylated Tyr-702 residue, these
authors demonstrated that Src phosphorylates Tyr-702 upon
mechanical stimulation, which activates TACE. Expression of a
TACE mutant in which the Tyr-702 residue is replaced by ala-
nine blocks TACE-activated TNFα release, p38 MAPK activation
and differentiation in mechanically stretched myoblasts. Further,
Src deficiency suppressed activation of p38 MAPK and myoge-
nesis in mechanically stretched myoblasts as well as in satellite
cells of overloaded soleus in mice. Consequently, overloading-
induced muscle regeneration is impaired in Src-deficient mice.
The presence of such stimulus-specific signaling mechanisms that
regulate TACE release of autocrine TNFα from MPCs provides
further support for TNFα as a key regulator of the myogenic
program responsible for the activation of p38 MAPK during
myogenesis.
OTHER CONSIDERATIONS
It is noteworthy that the effect of TNFα on myogenic differ-
entiation is highly complex. The effect of TNFα on myoblast
differentiation is bimodal. At physiological concentrations found
in injured muscle (up to 0.05 ng/ml), exogenously added TNFα
promotes myoblast differentiation. However, at higher concentra-
tions that are seen in inflammatory diseases exogenously added
TNFα inhibits myoblast differentiation, despite that its acti-
vation of p38 MAPK is intact (Chen et al., 2007). Indeed, a
number a studies that employed high concentrations of TNFα
reported similar inhibitory effect of TNFα on myoblast differen-
tiation (Guttridge et al., 2000; Langen et al., 2001; Trendelenburg
et al., 2012) or muscle regeneration (Moresi et al., 2008). The
paradoxical effects of TNFα on myogenesis illustrate the impor-
tance of distinguishing its physiological role from its pathological
roles.
Another issue of significance is that TNFα receptor-mediated
signaling is not required for embryonic myogenesis. Mice with
TNFα receptor double-knockout develop seemly normal mus-
cle. Myogenic activation of p38 MAPK during development
is likely mediated by the cell surface receptor Cdo (Kang
et al., 2008) or by amphoterin (HMGB1) through engaging
the receptor for advanced glycation end products (RAGE),
whose expression is developmentally regulated (Sorci et al.,
2004).
Further, p38 MAPK has been shown to promote satellite cell
activation and proliferation (Jones et al., 2005) through an asym-
metric activation pattern (Troy et al., 2012). However, whether
TNFα is responsible for p38MAPK activation during these events
is unknown.
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CONCLUSIONS
Recent progress indicates that TACE-released autocrine TNFα
from MPCs is a key mediator of p38 MAPK activation that
initiates myogenic differentiation through epigenetic regulations.
Emerging evidence also revealed that MPCs respond to diverse
environmental cues of muscle regeneration by activating p38
MAPK through the activation of TACE release of autocrine
TNFα through at least two distinct signaling pathways, namely,
the down-regulation of TIMP3 by miR-206 or the activation of
TACE by Src in a stimulus-dependent manner. Therefore, TACE-
mediated TNFα release from MPCs plays a key role in the re-
initiation of the myogenic program during muscle regeneration.
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